Ascendis Pharma A ASND
NASDAQ ASND
$270.81 -0.31 (-0.11%)
As of: Sep 4, 2026 · 3:58 PM EDT

Ascendis Pharma A (ASND) EPS (Diluted) (2014 - 2026)

Analysis

Ascendis Pharma A (ASND) EPS (Diluted) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 12.23
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 7.15
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.33 Bn 44.33 Bn - -3.06
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.15
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.06
10 Ascendis Pharma A 16.39 Bn 15.45 Bn 362.22 Mn 0.17
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.17
Mar 31, 2026 0.11
Dec 31, 2025 -1.16
Sep 30, 2025 -0.05
Jun 30, 2025 -0.05
Mar 31, 2025 0.00
Dec 31, 2024 0.03
Sep 30, 2024 0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 -0.05
Sep 30, 2023 0.02
Jun 30, 2023 -0.03
Mar 31, 2023 -0.03
Dec 31, 2022 0.07
Sep 30, 2022 -0.07
Jun 30, 2022 -0.02
Mar 31, 2022 0.01
Dec 31, 2021 -13.14
Sep 30, 2021 0.04